Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: Effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1

Cancer Research

Volumn 60, Issue 16, 2000, Pages 4602-4609

  Bissonnette, Marc ^d   Khare, Sharad ^d   Von Lintig, Friederike C ^c   Wali, Ramesh K ^d   Nguyen, Lan ^d   Zhang, Yingchun ^a,b   Hart, John ^a,b   Skarosi, Susan ^d   Varki, Nissi ^c   Boss, Gerry R ^c   Brasitus, Thomas A ^d  

^a Departments of Preventive Medicine   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Department of Medicine ^*  (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BETA CATENIN; COMPLEMENTARY DNA; CYCLIN D1; CYCLOOXYGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P21;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL CYCLE; COLON DISEASE; COLON TUMOR; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; MALE; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SINGLE STRAND CONFORMATION POLYMORPHISM;

ANIMALS; AZOXYMETHANE; BETA CATENIN; CARCINOGENS; COLONIC NEOPLASMS; CYCLIN D1; CYCLOOXYGENASE 2; CYTOSKELETAL PROTEINS; ENZYME ACTIVATION; GENES, RAS; ISOENZYMES; MALE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTO-ONCOGENE PROTEINS P21(RAS); RATS; RATS, INBRED F344; TRANS-ACTIVATORS;

EID: 0034662653     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
2. Prevalence of ras gene mutations in human colorectal cancers
3. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis
4. Genetic alterations during colorectal-tumor development
5. Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis
6. Mutations in the K-ras oncogene induced by 1, 2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa
7. β-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors
8. Chemotactic peptide-induced activation of Ras in human neutrophils is associated with inhibition of p120-GAP activity
9. Stimulation of p21ras upon T-cell activation
10. Ras-GTP levels are elevated in human NFl peripheral nerve tumors
11. 11 and -ζ
12. ras as a common signaling target of reactive free radicals and cellular redox stress
13. ras interaction
14. 1, 2-Dimethylhydrazine-induced alterations in protein kinase C activity in the rat preneoplastic colon
15. Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-K-ras transformed rat enterocytes
16. β-catenin regulates expression of cyclin D1 in colon carcinoma cells
17. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
18. Expression of the cyclin D1 gene in rat colorectal aberrant crypt foci and tumors induced by azoxymethane
19. Differential regulation of discrete apoptotic pathways by Ras
20. Regulation of the Ras signalling network
21. Increasing complexity of Ras signaling
22. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1
23. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2
24. The MAPK signaling cascade
25. Ets transcription factors: Nuclear effectors of the Ras-MAP-kinase signaling pathway
26. Cyclooxygenase 2 induction: Molecular mechanism and pathophysiologic roles
27. Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway
28. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
29. Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats
30. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors
31. Suppression of intestinal polyposis in Apc δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
32. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
33. Dietary calcium and vitamin D modulate 1, 2-dimethylhydrazine-induced colonic carcinogenesis in the rat
34. Analysis of K-ras, p53 and c-raf-1 mutations in beryllium-induced rat lung tumors
35. Determination of absolute amounts of GDP and GTP bound to Ras in mammalian cells: Comparison of parental and Ras-overproducing NIH 3T3 fibroblasts
36. A rapid, sensitive and specific method for the determination of protein in dilute solution
37. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
38. i
39. Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines
40. HER-2/neu signal transduction in human breast and ovarian cancer
41. ras-GTP formation
42. Mitogenic activation of the Ras guanine nucleotide exchange factor in NIH 3T3 cells involves protein tyrosine phosphorylation
43. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras
44. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis
45. Sequential analysis of K-ras mutations in aberrant crypt foci and colonic tumors induced by azoxymethane in Fischer-344 rats on high-risk diet
46. In vivo activation of mitogen-activated protein kinases in rat intestinal neoplasia
47. ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions
48. The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer
49. Regulation of cyclooxygenase-2 pathway by HER2 receptor
50. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
51. Target genes of β-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas
52. Identification of c-MYC as a target of the APC pathway
53. Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6JAPCMin/+ mice